For: | Vesic K, Gavrilovic A, Mijailović NR, Borovcanin MM. Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses. World J Psychiatry 2023; 13(4): 161-170 [PMID: 37123101 DOI: 10.5498/wjp.v13.i4.161] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v13/i4/161.htm |
Number | Citing Articles |
1 |
P.A. Zimina, K.V. Gubskaya, L.V. Sinitsyna, Ya.V. Malygin, A.A. Akhpashev. Etiology and pathogenesis of mental disorders in patients with multiple sclerosis: anxiety, psychotic, and personality disorders, chemical addictions, pathological affect. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery) 2024; (2): 195 doi: 10.33920/med-01-2402-03
|
2 |
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, Messias Gonzaga Pereira, Norberto Cysne Coimbra. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders. Basic & Clinical Pharmacology & Toxicology 2024; 134(5): 574 doi: 10.1111/bcpt.13997
|
3 |
Milica M. Borovcanin, Bojan Stojanovic, Milica Dimitrijevic Stojanovic, Bojana S. Stojanovic, Aleksandar Lazovic, Marina Mitrovic. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_394
|